Nautilus Biotechnology (NAUT) Assets Average (2020 - 2026)
Nautilus Biotechnology has reported Assets Average over the past 7 years, most recently at $184.4 million for Q1 2026.
- Quarterly results put Assets Average at $184.4 million for Q1 2026, down 21.58% from a year ago — trailing twelve months through Mar 2026 was $184.4 million (down 21.58% YoY), and the annual figure for FY2025 was $216.9 million, down 20.87%.
- Assets Average reached $184.4 million in Q1 2026 per NAUT's latest filing, down from $196.0 million in the prior quarter.
- Across five years, Assets Average topped out at $391.6 million in Q1 2022 and bottomed at $184.4 million in Q1 2026.
- Median Assets Average over the past 5 years was $297.1 million (2024), compared with a mean of $291.2 million.
- The largest annual shift saw Assets Average surged 232.52% in 2022 before it fell 22.23% in 2025.
- Over 5 years, Assets Average stood at $354.7 million in 2022, then fell by 12.05% to $312.0 million in 2023, then fell by 19.47% to $251.2 million in 2024, then fell by 21.98% to $196.0 million in 2025, then dropped by 5.9% to $184.4 million in 2026.
- Business Quant data shows Assets Average for NAUT at $184.4 million in Q1 2026, $196.0 million in Q4 2025, and $207.1 million in Q3 2025.